“At this stage there is no indication that vaccination with the AstraZeneca vaccine should be stopped,” said Bogdan Kirilov, Director of the Bulgarian Drug Agency in an interview for bTV.
“The evaluation of the European Medicines Agency (EMA) shows that the risk-benefit ratio is positive, that is why the recommendation is to continue administering the vaccine in compliance with the decision for its use,” he added. “Next week the agency is expected to deliver an opinion based on the additional analysis of safety data.”
There is no categorical recommendation at this point regarding the second dose of the vaccine even though some countries are now considering replacing it with an mRNA vaccine.
Bogdan Kirilov stated that the Oxford vaccine is the only vaccine in which interest has diminished, but that in the past few days 500-600 people a day have been taking the vaccine.
ITN continues to support the coalition agreement and to work with partners as a minority government. This was what MP Pavela Mitova said after the DPS of Ahmed Dogan announced that they were leaving the majority and the government of..
All artefacts from the exhibition in the USA "Ancient Thrace and the Classical World. Treasures from Bulgaria, Romania and Greece" are now home in the respective museums. This was what Deputy Minister of Culture Todor Chobanov..
In its session today, the Bulgarian Parliament will discuss the reasons for the second vote of no confidence in the government . It was submitted by "Moral, Unity and Honor" (MECH) party to the National Assembly's registry last week and supported by..
Together with PM Rosen Zhelyazkov we discussed the EU plan for a new Black Sea strategy which the European Commission will present soon, announced EU..
In an interview with public service TV BNT, Commissioner for Enlargement Marta Kos, who is on a working visit to Bulgaria, stated that Ukraine and the..
Half of the companies from the Bulgarian Industrial Capital Association say that the tariffs on the import of commodities announced by US President..
+359 2 9336 661